{Reference Type}: Case Reports
{Title}: Concentrically expanded reversed halo sign caused by nivolumab-related pneumonia.
{Author}: Tokuyasu H;Sato Y;Sueda Y;Sakai H;Esumi C;Yamasaki A;
{Journal}: Respirol Case Rep
{Volume}: 12
{Issue}: 5
{Year}: 2024 May
暂无{DOI}: 10.1002/rcr2.1352
{Abstract}: Among immune-related adverse events, pneumonitis is relatively uncommon, and nivolumab-related pneumonitis may present with a reversed halo sign.